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Objective: Over the last 15 years, researchers from around the world have developed
instruments for assessing the risk of conversion to psychosis. The objective of this article
is to review the literature on these instruments by focusing on genealogy links and on their
performance in predicting conversion to psychosis.
Method: A systematic review of articles published since 1980 relating to risk assessment
instruments for conversion to psychosis by manual search and consultation of electronic
databases MEDLINE, EMBASE, and PsycINFO.
Results:Three hundred ninety one (391) publications were selected and analyzed. Among
these, 22 instruments were identified.These instruments are briefly described and placed
on a timeline according to their year of publication. A code of positions, patterns, and forms
is used to schematize the characteristics of each instrument. A table is presented to show
changes in rates of conversion to psychosis within cohorts of subjects considered at risk
according to the instruments. A second code of shades and outlines is used to schematize
the characteristics of each cohort of patients. The two graphics set the stage for a dis-
cussion about the major strategies that were adopted to improve the performance of risk
assessment instruments.
Conclusion:These graphics allow a better understanding of the origin, evolution, current
status, strengths, shortcomings, and future prospects of research on risk assessment
instruments.
Clinical Implications
• The integration of theoretical approaches, the multicenter studies, and the pre-selection
of patients with short questionnaires were the main strategies to improve the
performance of instruments assessing the risk of conversion to psychosis.
• These instruments are better at predicting conversion to psychosis than conventional
variables within a more limited time span and can therefore enable the evaluation of
various risk factors and biomarkers that may be associated with psychosis.
Limitations
• The studies selected for this review of literature were not classified according to their
methodological quality.
• These studies are based on heterogeneous populations and this must be taken into
account when comparing the rates of conversion to psychosis.
• This review of literature was based on published data only and they were no direct
communication with the authors of these instruments.
Keywords: psychosis, prodrome, at risk mental state, ultra-high risk state, prediction and forecasting, review of
literature
INTRODUCTION
Beyond its economic implications, psychosis is a disease that all too
often has a lasting and painful impact on the patient’s life. In the
Abbreviations: ABC Study, age, beginning, and course study; ARMS, at risk men-
tal state; BPRS, brief psychiatric ratingscale; BSABS, Bonn scale for the assessment
hope of avoiding the most dramatic consequences, research groups
around the world have been working on psychosis prevention since
the early 1990s (McGlashan and Johannessen, 1996).
of basic symptoms; BSIP, Basel screening instrument for psychosis; BSLRP, Basel
screening list for risk of psychosis; CAARMS, comprehensive assessmentof at-risk
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Literature reviews show that a longer duration of untreated psy-
chosis is associated with higher scores for overall psychopathology,
positive symptoms and negative symptoms, and with a lower level
of functioning (Marshall et al., 2005; Perkins et al., 2005). This
observation has led to the creation of early intervention programs
that aim to reduce the duration of untreated psychosis in order to
ward off the disorder’s toxic effects on the brain.
Recently, the results of the TIPS, OPUS, and LEO studies have
contributed to the development of knowledge concerning early
intervention programs. In Scandinavia,Larsen et al. (2011) showed
that patients who had a shorter duration of untreated psychosis
achieved better results on scales of social functioning and negative,
depressive, and cognitive symptoms after 5 years of follow-up. The
OPUS study in Denmark and the LEO study in the UK showed
the beneficial effects of intensive treatment for patients experi-
encing a first psychotic episode, after 2 years and after 18 months,
respectively (Craig et al., 2004; Petersen et al., 2005). Unfortu-
nately, these beneficial effects were not maintained after 5 years of
follow-up (Bertelsen et al., 2008; Gafoor et al., 2010).
In light of these results, it is possible that the duration of
untreated psychosis is actually a marker of a more severe disease,
rather than a modifiable determinant of the course of the dis-
ease (McGlashan, 1999; Bosanac et al., 2010). Alternatively, it has
been suggested that even earlier interventions, before the psychosis
manifests itself, could change the course of the disease (McGlashan
and Johannessen, 1996).
In point of fact, an appreciable proportion of patients who
have experienced a psychotic episode will find it difficult to work
and socialize even if they have received early treatment and have
experienced a short duration of untreated psychosis (Addington
et al., 2003). This kind of disrupted functioning seems to develop
in the period preceding the onset of psychosis (Hafner et al.,
1999).
If we define conversion to psychosis as the transition from a
status without a psychotic disorder to a diagnosis of a psychotic
disorder (according to the clinical assessment or based on psy-
chometric scales), the development of instruments to evaluate the
mental states; CARE program, cognitive assessment and risk evaluation program;
CASH, comprehensive assessment of symptoms and history; COPS, criteria for
prodromal states; D3R, a selection of three of the criteria of prodromal schizophre-
nia according to the DSM-III-R; DSM-III-R, diagnostic and statistical manual of
mental disorders – third edition – revised; EDIE study, early detection and interven-
tion evaluation study; EPOS, European prediction of psychosis study; ERIraos, early
recognition inventory for the retrospective assessment of the onset of schizophrenia;
ESI, Eppendorf schizophrenia inventory; FCQ, Frankfurt complaint questionnaire;
GAF scale, global assessment of functioning scale; GHQ, general health question-
naire; IRAOS, interview for the retrospective assessment of the onset and course of
schizophrenia and other psychosis; NAPLS, North American prodrome longitudinal
study; PACE Clinic, personal assistance and crisis evaluation clinic; PANSS, posi-
tive and negative syndrome scale; PEPS, Palau early psychosis study; PRIME clinic,
prevention via risk identification, management and education clinic; PS-Revised,
PRIME-screen revised; PQ, prodromal questionnaire; RAP, recognition and pre-
vention program; SANS, scale for the assessment of negative symptoms; SAPS, scale
for the assessment of positive symptoms; SIPS, structured interview for prodromal
symptoms; SOPS, scale of prodromal symptoms; SPI-A, schizophrenia prediction
instrument – adult version; SPI-CY, schizophrenia prediction instrument – child
and youth version; SPQ, schizotypal personality questionnaire; SSP, self-screen pro-
drome; UHR-PS, ultra high risk psychosis scale; Y-PARQ, youth psychosis at risk
questionnaire.
risk of conversion to psychosis would make it possible to identify
individuals who will develop psychosis before the disease sets in
and therefore before their lives are disrupted. These people could
then receive treatments to mitigate, delay, or even prevent the
undesirable consequences. For more than 20 years, such instru-
ments have been developed and tested around the world, starting
with the scales created by Chapman and Chapman (1987), who
sought to identify individuals at risk of conversion to psychosis
beyond the genetic risk represented by the existence of a close rel-
ative with schizophrenia or an affective disorder with psychotic
characteristics.
However, the conversion rate in the cohorts of individuals iden-
tified as being at risk of developing psychosis are relatively low,
ranging from less than 10% to slightly over 50% within follow-
up periods ranging from 6 months to 10 years. In many centers,
it has also been observed that conversion rates decline with time
(Yung et al., 2007). In this context, the identification of individ-
uals who are at risk of conversion to psychosis itself poses a risk
of stigmatization, which is all the more problematic given that a
significant proportion of these people will not actually develop
psychosis. The idea of testing interventions on these individuals
is therefore a daunting one, because the interventions themselves
have a considerable risk of undesirable side effects (Cornblatt et al.,
2001).
In the face of these obstacles and ethical issues, research teams
have sought to improve the performance of their instruments.
Instruments for evaluating the risk of conversion to psychosis
have proliferated and it has become complicated to determine
the genealogy of each of these instruments. Where does a partic-
ular instrument come from? How is it related to a specific older
or newer instrument? And how well does it perform in predicting
psychosis? Based on schematic representations, this article aims
to answer these questions and help readers to find their way in a
fast-changing literature and to consider the future of research on
prodromal psychosis.
METHODS
To do this, a review of the literature on instruments designed
to evaluate the risk of conversion to psychosis was done by our
group from November 2009 to July 2011. The keywords psy-
chosis, prodrome, prodromal, at-risk mental state, ultra-high risk
state,prediction and forecasting,prospective study, schizophrenia and
disorders with psychotic features, preventive psychiatry and affective
disorders, psychotic were combined in the following search engines:
PsycINFO 1967–July week 2 2011, EMBASE 1980–2011 week 29,
and Ovid MEDLINE®1948–July week 2, 2011. Additional publi-
cations were obtained by a manual search of the references of the
publications that were found initially. These publications were read
and annotated by at least three of the authors (Danièle Blais, Jean-
Gabriel Daneault, and Emmanuel Stip). The publications retained
had to concern one or more instruments for evaluating the risk
of conversion to psychosis and to be written in English or French.
Particular attention was paid to previously published literature
reviews on these instruments to better understand their theoretical
bases.
The scales and other tools on which they were based were placed
on a timeline (Figure 1), and classified with a pattern code. The
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FIGURE 1 |Timeline of instruments assessing the risk of conversion to
psychosis. BSABS, Bonn scale for the assessment of basic symptoms;
IRAOS, interview for the retrospective assessment of the onset and course
of schizophrenia and other psychosis; FCQ, Frankfurt complaint questionnaire;
SPQ, schizotypal personality questionnaire; ESI, Eppendorf schizophrenia
inventory; SPI-A, schizophrenia prediction instrument – adult version; SPI-CY,
schizophrenia prediction instrument – child and youth version; UHR-PS, ultra
high risk psychosis scale; ERIraos, early recognition inventory for the
retrospective assessment of the onset of schizophrenia; DSM-III-R, diagnostic
and statistical manual of mental disorders – third edition – revised; ABC Study,
age, beginning, and course study; BSLRP, Basel screening list for risk of
psychosis; BSIP, Basel screening instrument for psychosis; SSP, self-screen
prodrome; CAARMS, comprehensive assessment of at-risk mental states;
Y-PARQ, youth psychosis at risk questionnaire; PANSS, positive and negative
syndrome scale; SOPS, scale of prodromal symptoms; CASH, comprehensive
assessment of symptoms and history; BPRS, brief psychiatric rating scale;
GAF Scale, global assessment of functioning scale; ARMS, at-risk mental
state; PACE clinic, personal assistance and crisis evaluation clinic; COPS,
criteria for prodromal states; SIPS, structured interview for prodromal
symptoms; PRIME Clinic, prevention via risk identification, management, and
education clinic; D3R, a selection of three of the criteria of prodromal
schizophrenia according to the DSM-III-R; SPQ, schizotypal personality
questionnaire; PQ, prodromal questionnaire; PS-revised, PRIME-screen
revised; EDIE Study, early detection and intervention evaluation study; GHQ,
general health questionnaire; RAP, recognition and prevention program; CARE
program, cognitive assessment and risk evaluation program; SANS, scale for
the assessment of negative symptoms; SAPS, scale for the assessment of
positive symptoms.
genealogical relations were represented with single arrows. A table
was prepared to show the change over time in the rates of con-
version to psychosis within the cohorts of subjects considered
to be at risk (Table 1). The publications retained for this table
had to concern samples of patients identified as being at risk of
conversion to psychosis by one or more evaluation instruments,
who had been followed up prospectively for at least 6 months and
on whom sociodemographic information was provided (at least
the mean age and percentages of men). Although most of these
cohorts underwent more intensive clinical follow-up (and thus
some kind of intervention), the publications that concerned more
formal treatments (such as a series of psychotherapy sessions or
a drug trial) were set aside. When a single cohort was the sub-
ject of several publications, only the most recent one was retained.
A second code involving shades of gray and border styles was estab-
lished to enable readers to distinguish the main characteristics of
each cohort.
RESULTS
The search in PsycINFO returned 240 publications, in EMBASE,
249, and in MEDLINE, 63. After adding the publications found
with a manual search and applying the inclusion and exclusion
criteria, we retained a total of 391 publications. Of this number,
181 publications (46.3%) came from Europe, 123 (31.5%) from
North America, 51 (13.0%) from Australia, 14 (3.6%) from Asia,
and 2 (0.5%) from Israel. Certain publications featured contribu-
tions by authors from several research centers around the world,
and 20 (5.1%) were classified as the outcome of a multicenter
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Table 1 | Changes in rates of conversion to psychosis within cohorts of subjects considered at risk.
BSABS, Bonn scale for the assessment of basic symptoms; ARMS, at-risk mental state; DSM-III-R, diagnostic and statistical manual of mental disorders – third
edition – revised; BSABS+DSM-III-R, combination of BSABS and DSM-III-R; SIPS, structured interview for prodromal symptoms; PRIME clinic, prevention via risk
identification, management and education clinic; RAP, recognition and prevention program; CAARMS, comprehensive assessment of at-risk mental states; CARE pro-
gram, cognitive assessment and risk evaluation program; SPI-A, schizophrenia prediction instrument – adult version; BSIP, Basel screening instrument for psychosis;
ERIraos, early recognition inventory for the retrospective assessment of the onset of schizophrenia; PS-revised, PRIME-screen revised; ESI, Eppendorf schizophrenia
inventory.
cooperative study. Several of these publications concerned the
follow-up of cohorts of patients at risk of conversion to psychosis
(155 or 39.6%). As well,71 reviews of the literature (or 18.2% of the
publications retained) enabled us to consolidate our knowledge of
the topic.
Through this search, we identified 22 instruments for evalu-
ation of the risk of conversion to psychosis. These instruments
were placed on the timeline based on their publication dates (see
Figure 1). Like Olsen and Rosenbaum (2006), we first classified
them according to two major approaches that predominate in
the research on the prodrome of psychosis. The instruments that
pay most attention to attenuated psychotic symptoms were placed
below the timeline. They aim to identify individuals at risk of
imminent conversion to psychosis. It should be recalled that atten-
uated psychotic symptoms are not risk factors as such. Rather,
they constitute what are generally called precursors of the disease
(Eaton et al., 1995).
The instruments that instead focus on basic symptoms were
placed in the upper half of the figure. The concept of basic
symptoms refers to the first phase of subjective disturbance (in
which the subject’s experience of volition, emotions, thoughts,
language, sensory perceptions, and motor actions becomes dif-
ferent or abnormal), which occurs at the very start of the
development of psychosis (Ruhrmann et al., 2010). In addition
to these two major schools of thought, there is a third cat-
egory of instruments comprising tools that combine theoreti-
cal concepts from both approaches. Thus, the closer an instru-
ment is to the center of the figure, the more it incorporates
elements from both schools of thought. Our comparison of
the instruments also allowed us to identify two different types
of tools: structured or semi-structured interviews that require
the presence of specialized investigators (placed in a rectangle)
and shorter questionnaires that may be self-administered (in
an oval).
Developed in Germany, the BSABS was designed to assess
the major categories of basic symptoms: “dynamic deficiencies”
(including emotional, perceptual, and action disorders), cogni-
tive problems, disorders affecting cenesthesia (the sense of bodily
existence), central neurovegetative disorders, and coping strategies
(Gross et al., 1987). In the Cologne Early Recognition project, 70%
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of subjects considered at risk by the BSABS developed schizophre-
nia after 9.6 years of follow-up (Klosterkotter et al., 2001). We have
not found any other publications that used the BSABS alone and
in its original version to follow-up subjects at risk of conversion
to psychosis.
The ERIraos is an instrument composed of the 10 BSABS items
with the greatest predictive validity for psychosis; it also incor-
porates the findings of the ABC Study on the period preceding
the onset of psychosis, based on a retrospective evaluation con-
ducted with a semi-structured interview, the IRAOS (Hafner et al.,
1998). The evaluation takes place in two sessions. Subjects are
invited to undergo an interview on the basis of their scores on a
screening questionnaire, which may be self-administered (Hafner
et al., 2004). In the German Research Network on Schizophrenia,
Hurlemann et al. (2008) found that 22.2% of a group of subjects
identified as at risk by the ERIraos had developed psychosis at the
end of an 18-month follow-up. Another cohort deemed at risk
by the ERIraos showed a 40.3% conversion rate after a median
follow-up period of 32 months (Bodatsch et al., 2011).
The SPI-A was developed further to a facet- and data-cluster-
based analysis of the basic symptoms reported by subjects at risk of
conversion to psychosis in the Cologne Early Recognition project
(Schultze-Lutter et al., 2004, 2007). The SPI-A was used by itself
in a publication that showed that 34.9% of a group of subjects
considered to be at risk presented a psychotic illness at the end
of a 20.6-month follow-up period (Schultze-Lutter et al., 2007).
When the SPI-A was used together with SIPS, the conversion rate
was 29% at the end of 3 years (Huang et al., 2007) and 41% at the
end of 5.1 years of follow-up (Koethe et al., 2009).
Since the results of these analyses were very different in chil-
dren and adolescents, a version for subjects aged 8- to 18-years-old
was developed at the University of Heidelberg. This instrument,
the SPI-CY emphasizes the distinction between basic symptoms
and other clinical pictures in child psychiatry and incorporates
parents’ observations (Koch et al., 2007). At the time of writing,
no publication had yet reported rates of conversion to psychosis
associated with the SPI-CY.
The criteria for an at-risk mental state (ARMS) were first oper-
ationalized by the research team at the PACE Clinic in Melbourne,
VIC, Australia. They refer to three groups of patients: patients
who present attenuated psychotic symptoms (i.e., symptoms that
are significantly different from normal without reaching psychotic
intensity, according to the CASH and the BPRS); patients who
present what are known as Brief Limited Intermittent Psychotic
Symptoms or BLIPS (i.e., symptoms at the psychotic level of
intensity according to the CASH and BPRS, but that clear up spon-
taneously within less than a week); and patients who present risk
factors combined with an at-risk state or trait and state risk factors
[i.e., subjects between the ages of 14 and 30 who present a schizo-
typal personality or a family background of psychotic disorders
as defined by the DSM-IV (Diagnostic and Statistical Manual of
Mental Disorders – Fourth Edition), with sufficient disturbance
of their mental state to decrease their score on the Global Assess-
ment of Functioning (GAF) scale by at least 30 points] (McGorry
et al., 1996; Yung et al., 1996). The conversion rates associated
with the ARMS criteria have remained relatively stable (or with a
slight downward trend) over time (e.g., at the PACE Clinic, after
12 months of follow-up, the rate was 48% in 1998 vs. 33.3% in
2002 vs. 34.3% in 2009) (Yung et al., 1998; Phillips et al., 2002; Sun
et al., 2009).
The EDIE Study also applies these criteria, but it does not use
the CASH and the BPRS, defining the level of psychotic intensity
by means of the PANSS instead. A decline of at least 30 points on
the GAF is still considered to be a criterion for an at-risk state, but
it may also be defined by a positive score on the GHQ (Morrison
et al., 2002). The EDIE Study is a randomized controlled study in
which 35 subjects considered to be at risk of conversion received
6 months of cognitive therapy, while 23 other subjects also con-
sidered to be at risk received regular follow-up. After 36 months,
conversion rates were 20 and 22%, respectively (not a statistically
significant difference) (Morrison et al., 2007). Given that this was
a randomized controlled study, this result has not been retained
for the remainder of the discussion.
In addition to assessing the criteria for ARMS, as defined above,
the semi-structured interview in the CAARMS makes it possi-
ble to investigate basic symptoms (Yung et al., 2005). We can
see a downward trend in the conversion rates associated with the
CAARMS. Lam et al. (2006) reported a 29% conversion rate after
6 months of follow-up, whereas Yung et al. (2008) found a rate of
16% after 24 months, Demjaha et al.’s (2012) rate was 14.8% after
24 months; finally, Nelson et al.’s (2011) study had a rate of 8.8%
after 6 months.
The Y-PARQ is an instrument with 92 items to which the
respondent can answer “yes,”“no,” or “unknown.” It was based on
the CAARMS and was developed for the PEPS study, which investi-
gated teens on Palau,a Pacific island where there is a high frequency
of familial schizophrenia (Ord et al., 2004; Myles-Worsley et al.,
2007a,b). At the time of writing, no publication had yet reported
rates of conversion to psychosis associated with the Y-PARQ.
The SIPS is a semi-structured interview developed by Miller
and McGlashan at the PRIME clinic in New Haven, Connecticut,
to evaluate the severity of ARMS, as defined by Yung and McGorry.
It is made up of the SOPS, which is modeled on the PANSS, and of
the GAF, the criteria for schizotypal personality disorder accord-
ing to the DSM-IV, and the COPS (Miller et al., 1999). It is not
possible to detect any clear downward or upward trend when we
analyze changes in the conversion rates associated with the SIPS.
These conversion rates range from 13.5% after a 12-month follow-
up (Simon and Umbricht, 2010) to 57.1% after 24 months (Miller
et al., 2003).
The SIPS was used by theRAP program at Zucker Hillside Hos-
pital in New York to define Clinical High Risk (CHR). According to
this research strategy, patients are at risk of conversion to psychosis
if they present attenuated positive symptoms (or CHR+), but
also if they manifest attenuated negative symptoms (or CHR−)
(Cornblatt et al., 2003). In a publication from 2003, 14.5% of
subjects identified as being at risk of conversion developed psy-
chosis after approximately 12 months (Cornblatt et al., 2003). In
another cohort, 19% of subjects presented a psychotic illness after
12 months’ follow-up (Cornblatt et al., 2007).
The SIPS is also used by the CARE program at the University
of San Diego. Subjects considered to be at risk of conversion go
through a battery of tests including the SIPS, the SANS, the SAPS,
and the BPRS, to better take into account the negative symptoms
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and disorganized behaviors into risk assessment (Haroun et al.,
2006). There seems to be a downward trend in the conversion rates
associated with the SIPS as used in the CARE program. Haroun
et al. (2006) reported that 30% of subjects considered to be at risk
had developed psychosis after 3 years of follow-up. However, in a
2010 publication, only 12.5% of subjects considered to be at risk
had developed a psychotic illness. Nevertheless, this reduced rate
must be interpreted in the context of a shorter follow-up period,
18 months (Jahshan et al., 2010).
The PRIME-screening test or PRIME-screen or SIPS-screen is
composed of 12 items from the SIPS. It is a screening test that can
be self-administered in front-line clinics (Miller et al., 2004). A
modified version, the PS-revised (or PRIME-screen revised), was
developed by a Japanese team that added a section on the dura-
tion of symptoms to improve its specificity (symptoms present for
a longer time are considered to be more representative of being
at risk of conversion to psychosis) (Kobayashi et al., 2008; Morita
et al., 2010). Together with the SIPS, this screening test was tested
on a population of 35 subjects identified as being at risk of con-
version to psychosis; 14.8% of them developed psychosis after
6 months (Kobayashi et al., 2008).
Inspired by the SIPS and the SPQ, the PQ is a self-evaluation
screening instrument made up of 92 “true or false” statements.
Created at the University of California, Los Angeles, it seeks to
identify subjects who are potentially at risk of conversion to
psychosis before they undergo a more formal risk assessment inter-
view (Loewy et al., 2005). The PQ-brief is a modified version of
the original PQ. Its 21 items are essentially the outcome of the
selection and revision of statements concerning positive symp-
toms (Loewy et al., 2011). At the time of writing, no publication
had reported rates of conversion to psychosis associated with the
PQ or PQ-brief.
The ESI is a 40-item questionnaire that attempts to evalu-
ate disorders affecting psychotic patients’ experience of cognitive
functions (Mass et al., 2005). It is inspired by the BSABS, the
FCQ (Sullwold and Huber, 1986), and the SPQ (Raine, 1991).
Niessen et al. (2010) used it in a sample that included subjects
who requested psychological help and patients with a mental ill-
ness. The ESI proved to be able to distinguish between patients
with active psychosis and subjects at risk of conversion. When
used with the BSABS and the SIPS, the ESI was able to identify 64
subjects considered to be at risk of conversion. After 36 months’
follow-up, 20.3% of these subjects had developed a psychotic ill-
ness (Niessen et al., 2010). A selection of five items from the ESI
led to the creation of the UHR-PS, which could potentially make
it easier to screen at risk patients (Niessen et al., 2010).
The DSM-III-R also suggests criteria for identifying prodromal
schizophrenia. These criteria are relatively unspecific, especially in
the adolescent population (McGorry et al., 1995). On the other
hand, Horneland et al. (2002) found that three of the criteria
(“peculiar behavior,” “magical thinking,” and “unusual perceptual
experiences” – D3R) more specifically indicate an increased risk of
conversion to psychosis. In a sample of 501 subjects with at least
one DSM-III-R criterion for prodrome, the D3R identified 20 sub-
jects as being at risk of conversion to psychosis; 3 of them (15%)
developed a psychosis after 6 months of follow-up (Horneland
et al., 2002).
The FEPSY-Projekt (or Basel early detection of psychosis study)
in Switzerland led to the development of several instruments
inspired by the DSM-III-R criteria, but also by the literature on
prodromal psychosis (with the use of data obtained in the ABC
Study, among other things). The BSLRP is a short screening ques-
tionnaire designed to help general physicians make decisions about
referring potentially at risk subjects for more specialized services
(Asston et al., 2002; Gschwandtner et al., 2003). The BSIP includes
46 items, but is intended for psychiatrists working with a popula-
tion that has requested mental health assistance (Riecher-Rossler
et al., 2007). The SSP is a self-evaluation screening tool made up
of 32 true or false questions (Mueller et al., 2009; Muller et al.,
2010). The conversion rates associated with the BSIP show the
following trend: used in conjunction with the ARMS criteria,
34% conversion to psychosis after 25 months (Borgwardt et al.,
2007), likewise 34% but after 5.4 years (Riecher-Rössler et al.,
2009) and 28.6% after 6 years of follow-up (Gschwandtner et al.,
2009).
The PROD-screen is a 29-question screening questionnaire
inspired by the SIPS, the IRAOS, and the BSABS (Heinimaa
et al., 2003). Because of its concise and simple format, it can be
self-administered or administered over the telephone to identify
subjects who should be evaluated in more depth with a semi-
structured interview. At the time of writing, there had not yet
been any publications reporting the rate of conversion to psychosis
associated with the PROD-screen.
Most of these instruments were tested on cohorts of subjects
considered to be at risk of conversion to psychosis. Table 1 shows
the changes in the rates of conversion to psychosis over time, as a
function of the instrument used.
DISCUSSION
One of the first observations that emerge from the analysis of
Figure 1 is that the timeline is loaded with a large number
of instruments. These various instruments are the outcome of
repeated revisions of earlier instruments on the basis of statistical
analyses (which have often sought, among other things, to deter-
mine the criteria that best predict conversion to psychosis) and
based on the clinical experience of the researchers involved and
the obstacles they encountered.
Faced with rather low rates of conversion to psychosis, sev-
eral research teams have attempted to combine the two major
approaches for evaluating prodromal psychosis (i.e., the approach
based on attenuated psychotic symptoms and the one based on
basic symptoms). This is well represented in Figure 1 by the
appearance over time of instruments such as the CAARMS and
the PROD-screen, which have been placed in the center of the
diagram to make their theoretical foundations clear. This is also
shown in Table 1, where one can clearly see that research teams
are investing more and more time in combining evaluation tools
so they can make use of both approaches. It is postulated that
this combination will make it possible to identify the groups of
subjects who are most representative of patients who will develop
psychosis (Simon et al., 2006).
But this reconciliation of the two approaches is not suffi-
cient to mitigate the differences between the various research
teams. Differences remain between the characteristics of the basic
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population, the recruitment of patients, the evaluation process,
the follow-up, the treatments provided, etc. This is why there was
the creation of several multicenter studies (the PRIME project, the
NAPLS, and the EPOS). In addition to enabling researchers to test
evaluation instruments on a much larger population, these stud-
ies are pursuing the homogenization of the process of evaluating
subjects at risk of conversion to psychosis. This homogenization
makes it easier to compare the results of research on these subjects,
which had formerly been difficult and risky.
Figure 1 also shows that questionnaires to facilitate screening
have proliferated in recent years. In this regard, it is important to
remember that the first publications on the evaluation of the risk
of conversion to psychosis concerned very well-selected cohorts
of subjects. Those subjects were usually referred by mental health
professionals who already suspected that a psychotic process was
developing. In this context, it is crucial to develop shorter instru-
ments that can be completed in the form of a self-evaluation
or a telephone interview by a non-specialist evaluator to sep-
arate out the subjects who need an in-depth interview with a
specialist in prodromal psychosis and the subjects who have non-
specific complaints that can be handled by first-line services. It
has in fact been shown that patients are quite reliable at reporting
psychotic-type symptoms, as indicated by the good match between
self-evaluations and evaluations done by specialized observers
(Lincoln et al., 2010).
We should point out that the way subjects get into programs
for evaluating the risk of conversion probably has a great influ-
ence on the proportion of subjects who will develop psychosis out
of the total cohort of patients considered to be at risk. Yung et al.
(2007) hypothesized that quicker referral could explain the decline
in conversion rates observed in recent years by several screening
programs for early psychosis (Yung et al., 2007). This aspect is well
represented in Table 1, where the table fields are increasingly likely
to be pale gray (indicating low conversion rates of approximately
0–20%) as time passes, despite the fact that their borders become
thicker and darker (indicating that follow-up periods are longer,
up to 2 years or more).
Despite their relatively low positive predictive value, it should be
emphasized that these evaluation instruments are better at predict-
ing conversion to psychosis than conventional variables (e.g., fam-
ily background of psychotic disorders) within a more limited time
span (Cannon, 2008). They make it possible to identify cohorts in
which 10–50% of individuals will develop psychosis after approx-
imately 2–3 years of follow-up. These cohorts are therefore fertile
ground for evaluating the predictive value of various risk factors
and biomarkers that may be associated with conversion to psy-
chosis. As an example, Thompson et al. (2011) reported that three
clinical variables that enhanced the predictive validity of an even-
tual conversion to psychosis (i.e., family history of psychosis with
functional decline, high scores for unusual thought content, and
poor overall level of functioning) in a sample of at risk patients
studied by the NAPLS consortium also significantly improved
the predictive validity of an eventual conversion to psychosis in
a sample of at risk patients studied at the PACE clinic in Mel-
bourne, VIC, Australia. These cohorts should also make it easier
to study the onset of clinical manifestations of psychosis. A better
understanding of the first signs and symptoms of the disease could
eventually enable clinicians to make earlier and more solidly based
diagnoses.
CONCLUSION
These results show how these instruments are evolving. They
are constantly being revised as a function of the clinical and
ethical challenges represented by research on the prodrome of psy-
chosis. This is what we have attempted to schematize in Figure 1.
One limitation on Figure 1 is that, although it clearly shows the
genealogical relations between the different instruments, it may
not make it sufficiently clear that some advances are based on the
generation of new tools in an essentially spontaneous and intuitive
way. The creation of this figure also led us to examine the vari-
ations in these instruments’ performance. We represented these
variations in Table 1 in the form of conversion rates to psychosis
within cohorts of patients considered to be at risk. This presen-
tation is limited by the lack of information on each instrument’s
sensitivity and specificity. Unfortunately, most of the publications
examined present only a group of subjects considered to be at risk
of conversion to psychosis (without comparison with a control
group of subjects considered to have little or no risk of conver-
sion). Thus, it was not always possible to calculate (and present)
these parameters. Another limitation is the lack of information
provided about the subjects’ origins or the specific features of
their referral for assessment of the risk of conversion to psychosis.
Several of the publications simply mention that the subjects were
help-seekers who were seen by front-line health care profession-
als and then referred to general mental health clinics or more
specialized clinics due to a suspicion that they were experienc-
ing the onset of a psychotic illness. Given that epidemiological
studies have shown that, in the general population, the experience
of psychotic symptoms may be relatively frequent (approximately
5%), and that they are generally transitory (van Os et al., 2009),
it appears probable that, beyond the quality of the evaluations
done with the various instruments, the way in which the subjects
were selected is also important. It is possible that the groups were
very different in terms of the subjects’ origins and how they were
referred to the evaluators. It is also possible that such differences
explain some of the variation in conversion rates at the follow-up
sessions.
One of the next steps could be to push the analysis further
and to consider changes in these patients’ distress levels and func-
tioning. As Ruhrmann et al. (2010) emphasize, it has been shown
that a high proportion of these patients have to cope with dis-
rupted social and occupational functioning and deterioration in
their quality of life, regardless of whether or not they convert to
psychosis (Ruhrmann et al., 2010). Instruments for evaluating the
risk of conversion to psychosis could also measure symptomatic
and functional impairment separately. It would then make it pos-
sible to identify these suffering and dysfunctioning patients so that
they can be offered the appropriate health care services.
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